BIOSUIS M. hyo emulsion for injection for pigs
BIOSUIS M.hyo - inactivated vaccine for active immunization of porkers and mitigation of consequences of the infections with Mycoplasma hyopneumoniae – bacteria causing porcine enzootic pneumonia
|type of preparative:||Vaccines|
|target species animals:||Pig|
QUALITATIVE AND QUANTITATIVE COMPOSITION
One vaccine dose (2.0 ml of vaccine) contains:
Mycoplasma hyopneumoniae, inactivatum RP ≥ 1*
*RP = Relative potency (ELISA) by comparison with reference serum obtained from mice after vaccination with vaccine batch conforming to challenge test on target animal.
Adjuvant: Montanide ISA 35 VG 0.2 ml
Excipients:Formaldehyde 35% max. 2 mg, thiomersal 0.17 – 0.23 mg
Emulsion for injection. Milky liquid of yellowish-white to light pink colour without sediment or with small amount of sediment dispersing after shaking.
1 dose after the pig´s age of 10 days, in the case of strong infection pressure it is possible to administer 2 doses, the first dose after the pig´s age of 7 days and the second one in the time interval of 3 weeks
Vaccine dose 2 ml
Pigs (fattening pigs)
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The vaccine is intended for active immunization of fattening pigs to mitigate the effects of infection with Mycoplasma hyopneumoniae - a causative agent of enzootic pneumonia in pigs. Active immunity starts in vaccinated piglets 21 days after vaccination, or revaccination if 2 doses are applied. Vaccine ensures duration of immunity during fattening.
Do not use in case of any acute or febrile illness.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Only clinically healthy animals can be vaccinated.
During the vaccination is necessary to avoid stressing of animals
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This product contains oil. Accidental injection/self injection may result in severe pain and swelling, paricularly if injected into a join or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek promt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
Local reactions up to 3 cm in diameter can occur after application, which disappear spontaneously within 3 days. Some animals may manifest a transient increase in body temperature max. 1°C.
Occasionally hypersensitive reaction may occur. In this case, you must promptly initiate appropriate treatment.
USE DURING PREGNANCY AND LACTATION
The use is not recommended during pregnancy and lactation.
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
AMOUNTS TO BE ADMINISTERSD AND ADMINISTRATION ROUTE
Vaccination: 2-ml dose of the vaccine should be administered according to the following schedule:
1 dose after day 10 of age. In the farms with high infection pressure by Mycoplasma hyopneumoniae two doses at an interval of 3 weeks can be used from 7 days of age. Selection of the vaccination schedule depends on knowing the disease incidence on a particular farm.
Method of administration: intramuscularly, preferably into the paraauricular region.
Before use heat the contents of the vial to room temperature 15 – 20 °C and well shake.
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: 10 hours.
SPECIAL PRACAUTIONS FOR STORAGE
Store in a refrigerator (2 °C - 8 °C). Protect from light. Protect from frost.
1 x 50 doses (100 ml), 1 x 125 doses (250 ml)
+420 517 318 598